Legendary Crystallographer Donald Caspar Dies At 94

He coined the term “structural biology.”

Written byLisa Winter
| 2 min read
Donald Caspar smiling into camera holding a buckyball model
Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Donald Caspar, best known for his work determining the structure of the tobacco mosaic virus, died on November 27, 2021 at the age of 94. He is also credited with creating the term “structural biology” to describe the burgeoning field.

Caspar was born in Ithaca, New York, on January 8, 1927. According to a tribute in Nature by Caspar’s former PhD student Lee Makowski, his father was a chemist and he became interested in topics discussed at home, particularly the first clues about the structure of tobacco mosaic virus (TMV). He earned a physics degree from Cornell University in 1950 and attended Yale University for graduate school, focusing on the structure of TMV for his biophysics thesis.

After obtaining his PhD in 1955, he received a fellowship to King’s College London, where he worked under Rosalind Franklin until the following year. The pair published interrelated papers in Nature describing that ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Lisa joined The Scientist in 2017. As social media editor, some of her duties include creating content, managing interactions, and developing strategies for the brand’s social media presence. She also contributes to the News & Opinion section of the website. Lisa holds a degree in Biological Sciences with a concentration in genetics, cell, and developmental biology from Arizona State University and has worked in science communication since 2012.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies